Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells

Experimental Dermatology

Volumn 16, Issue 3, 2007, Pages 171-178

  Tuettenberg, Andrea ^a   Koelsch, Stephan ^b   Knop, Jürgen ^a   Jonuleit, Helmut ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Merck Selbstmedikation GmbH   (Germany)

Author keywords

Dendritic cells; Immunomodulation; Oxymetazoline; Proinflammatory cytokines; Rhinitis

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OXYMETAZOLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; NASAL DECONGESTANTS; OXYMETAZOLINE; RHINITIS; T-LYMPHOCYTES;

EID: 33846996395     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00527.x     Document Type: Article

References (30)

1. van Benten I, Koopman L, Niesters B et al. Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol 2003: 14: 363-370.
2. Turner R B. New considerations in the treatment and prevention of rhinovirus infections. Pediatr Ann 2005: 34: 53-57.
3. van Kempen M, Bachert C, Van Cauwenberge P. An update on the pathophysiology of rhinovirus upper respiratory tract infections. Rhinology 1999: 37: 97-103.
4. Gern J E, Vrtis R, Grindle K A, Swenson C, Busse W W. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000: 162: 2226-2231.
5. Gentile D A, Skoner D P. Viral rhinitis. Curr Allergy Asthma Rep 2001: 1: 227-234.
6. Igarashi Y, Skoner D P, Doyle W J, White M V, Fireman P, Kaliner M A. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993: 92: 722-731.
7. Thomas L H, Wickremasinghe M I, Sharland M, Friedland J S. Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection. J Virol 2000: 74: 8425-8433.
8. Bachert C, van Kempen M J, Hopken K, Holtappels G, Wagenmann M. Elevated levels of myeloperoxidase, pro-inflammatory cytokines and chemokines in naturally acquired upper respiratory tract infections. Eur Arch Otorhinolaryngol 2001: 258: 406-412.
9. Kubach J, Becker C, Schmitt E et al. Dendritic cells: Sentinels of immunity and tolerance. Int J Hematol 2005: 81: 197-203.
10. Banchereau J, Steinman R M. Dendritic cells and the control of immunity. Nature 1998: 392: 245-252.
11. Jonuleit H, Knop J, Enk A H. Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res 1996: 289: 1-8.
12. Jacobs J J L, Lehé C L, Hasegawa H, Elliott G R, Das P K. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 2006: 15: 432-440.
13. Melief C J. Regulation of cytotoxic T lymphocyte responses by dendritic cells: Peaceful coexistence of cross-priming and direct priming? Eur J Immunol 2003: 33: 2645-2654.
14. Camporeale A, Boni A, Iezzi G et al. Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res 2003: 63: 3688-3694.
15. Granucci F, Vizzardelli C, Virzi E, Rescigno M, Riccardi-Castagnoli P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 2001: 31: 2539-2546.
16. Maestroni G J. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol 2000: 165: 6743-6747.
17. Felsner P, Hofer D, Rinner I, Porta S, Korsatko W, Schauenstein K. Adrenergic suppression of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha 2-receptors. J Neuroimmunol 1995: 57: 27-34.
18. Reinecke S, Tschaikin M. Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis. MMW Fortschr Med 2005: 147: 113-118.
19. Jonuleit H, Giesecke-Tuettenberg A, Tuting T et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 2001: 93: 243-251.
20. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk A H. Induction of interleukin 10-producing, non-proliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000: 192: 1213-1222.
21. Stassen M, Fondel S, Bopp T et al. Human CD25+ regulatory T cells: Two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004: 34: 1303-1311.
22. Roseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1995: 252: 61-63.
23. Gentile D A, Villalobos E, Angelini B, Skoner D. Cytokine levels during symptomatic viral upper respiratory tract infection. Ann Allergy Asthma Immunol 2003: 91: 362-367.
24. Sethi S K, Bianco A, Allen J T, Knight R A, Spiteri M A. Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol 1997: 110: 362-369.
25. Dearman R J, Bhushan M, Cumberbatch M, Kimber I, Griffiths C E M. Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation. Exp Dermatol 2004: 13: 452-460.
26. Browning S, Housley D, Richards R, Eccles R. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa. Acta Otolaryngol 1997: 117: 851-855.
27. Beck-Speier I, Dayal N, Karg E et al. Oxymetazoline inhibits proinflammatory reactions: Effect on arachidonic acid-derived metabolites. J Pharmacol Exp Ther 2006: 316: 843-851.
28. Bjerknes R, Steinsvag S K. Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decongestive nosedrops. Pharmacol Toxicol 1993: 73: 41-45.
29. Kang B Y, Lee S W, Kim T S. Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogen-activated protein kinase by alpha2-adrenoceptor agonists. Eur J Pharmacol 2003: 467: 223-231.
30. Feng G J, Goodridge H S, Harnett M M et al. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 1999: 163: 6403-6412.